{"name":"Gliknik Inc.","slug":"gliknik-inc","ticker":"","exchange":"","domain":"gliknik.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GL-0817","genericName":"GL-0817","slug":"gl-0817","indication":"Relapsed or refractory multiple myeloma","status":"phase_2"}]}],"pipeline":[{"name":"GL-0817","genericName":"GL-0817","slug":"gl-0817","phase":"phase_2","mechanism":"GL-0817 is an anti-CD47 monoclonal antibody.","indications":["Relapsed or refractory multiple myeloma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOS1VhcTVnc1FZd2UydXRaWW55SW1GOUhfcm1RUC1BbkpWQUdFa0RscHhscS1PNk4tcE5JUFJnMlUtbnQ0MFZMV1lJakpPUU1iX0lwQUJ4SjJ4OHo0N3FCNFFjSlpMLVBvVTdwbEFPUWtKTUpacTJ0cWxtOEdmRzM1OWFiVTZUblRoSUpUZGhIdUt5N0RNYk5rZHFIQnhmQdIBngFBVV95cUxOS1VhcTVnc1FZd2UydXRaWW55SW1GOUhfcm1RUC1BbkpWQUdFa0RscHhscS1PNk4tcE5JUFJnMlUtbnQ0MFZMV1lJakpPUU1iX0lwQUJ4SjJ4OHo0N3FCNFFjSlpMLVBvVTdwbEFPUWtKTUpacTJ0cWxtOEdmRzM1OWFiVTZUblRoSUpUZGhIdUt5N0RNYk5rZHFIQnhmQQ?oc=5","date":"2008-09-18","type":"deal","source":"Newswise","summary":"Gliknik Signs License for Promising Cancer Therapeutic Vaccines | Newswise - Newswise","headline":"Gliknik Signs License for Promising Cancer Therapeutic Vaccines | Newswise","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}